Horizon scanning for pharmaceutical disease modifying treatments for Alzheimer’s disease across high-income countries
Background: Horizon Scanning (HS) is a tool that can be used to inform healthcare decision makers and aid health system preparedness for the potential introduction of novel health technologies (i.e. pharmaceuticals, medical devices, diagnostics, and digital interventions). This is of particular benefit [for full text, please go to the a.m. URL]
Publication Details
- Journal
- German Medical Science (German Research Foundation)
- Published
- 2025-06-06
- DOI
- https://doi.org/10.3205/24ffhsc16
- Primary Topic
- Protist diversity and phylogeny
- Type
- article
- Field-Weighted Citation Impact
- 0.00